Search

Viatris Inc

Chiusa

SettoreSettore sanitario

16.51 0.73

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

16.48

Massimo

16.59

Metriche Chiave

By Trading Economics

Entrata

-295M

-119M

Vendite

240M

3.8B

EPS

0.69

Rendimento da dividendi

2.83

Margine di Profitto

-3.162

Dipendenti

30,000

EBITDA

9.4M

653M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+18.54% upside

Dividendi

By Acuity

Rendimento da dividendi

Media del settore

2.83%

2.18%

Utili prossimi

5 nov 2026

Prossima data del Dividendo

16 set 2026

Prossima data del' Ex Dividendo

23 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-1.1B

19B

Apertura precedente

15.78

Chiusura precedente

16.51

Viatris Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

11 set 2026, 21:41 UTC

Shares of Viatris Inc. declined in after-market trading, reflecting a notable dip from earlier highs and a cumulative return of -0.36% since Friday's close.

10 set 2026, 20:07 UTC

Viatris Inc shares are lower amid a broader market decline, reflecting ongoing economic concerns. The stock has seen five consecutive daily closes lower.

9 set 2026, 19:36 UTC

News

Viatris shares are lower today despite Leerink Partners initiating coverage with an Outperform rating and a price target of $20.

8 set 2026, 19:46 UTC

Viatris Inc shares are lower today, influenced by broader market declines and rising Brent crude prices amid geopolitical tensions. No specific company news was identified.

4 set 2026, 22:14 UTC

Viatris Inc is gaining in after-market trading, rising above its 20-day moving average and reaching a session high since Friday's close.

3 set 2026, 19:56 UTC

Viatris Inc is trading lower, reflecting broader market trends. The stock reached a session low earlier, with no specific news identified for the movement.

2 set 2026, 19:46 UTC

Viatris Inc. shares are trading higher during Wednesday's session, remaining above the 20-day moving average amid rising U.S. Treasury yields.

1 set 2026, 20:09 UTC

Viatris Inc shares are higher, supported by strength in the Pharmaceuticals sub-sector. Earlier, the stock pulled back from a session high.

31 ago 2026, 23:14 UTC

Shares of Viatris Inc. traded lower during after-market hours, reflecting broader market sentiment amid rising crude oil prices and geopolitical tensions.

28 ago 2026, 19:51 UTC

Viatris Inc shares are trading lower today, breaking a trend of higher daily closes. No specific news has been identified to explain the decline.

27 ago 2026, 23:02 UTC

Shares of Viatris Inc. traded lower in after-market hours. No specific company news was identified to explain the decline.

26 ago 2026, 23:01 UTC

Shares of Viatris Inc declined in after-market trading, dropping from a peak to a low following four consecutive sessions of gains. No specific news was identified.

25 ago 2026, 23:01 UTC

Viatris Inc shares are lower in after-market hours, reflecting a notable decline. The broader market initially showed strength but has since reversed some gains.

24 ago 2026, 19:56 UTC

Viatris Inc shares are higher today, continuing a positive trend since Friday. Broader market conditions include a significant drop in crude oil prices.

21 ago 2026, 23:01 UTC

Viatris Inc shares are lower in after-market hours, continuing a decline since Friday's close, with no specific news identified to explain the movement.

20 ago 2026, 20:06 UTC

Viatris Inc shares are declining amid broader market trends, remaining below their 20-day moving average. Earlier in the session, shares briefly upticked before pulling back.

19 ago 2026, 23:06 UTC

Viatris Inc. shares moved higher in after-market trading, despite remaining below the 20-day moving average and near the lower end of the one-month range.

18 ago 2026, 23:01 UTC

Viatris Inc shares rose in after-market trading, recovering from session lows. This increase comes amid broader market concerns over rising U.S. Treasury yields.

17 ago 2026, 23:16 UTC

Viatris Inc shares are trading higher in after-market hours, following earlier directional movement. No specific news was identified to explain the price action.

14 ago 2026, 20:06 UTC

Viatris Inc shares are higher today, despite earlier session pullbacks. Broader market sentiment is mixed following a decline in U.S. retail sales.

13 ago 2026, 20:06 UTC

Viatris Inc shares are lower today, reflecting broader market trends amid rising U.S. jobless claims that exceeded expectations. The stock remains near its one-month range low.

12 ago 2026, 23:06 UTC

Viatris Inc. shares moved higher in after-market trading, recovering from earlier losses. The stock remains below its 20-day moving average.

11 ago 2026, 23:41 UTC

Viatris Inc. shares rose in after-market trading, despite earlier fluctuations and broader market concerns about inflationary pressures and oil prices.

10 ago 2026, 19:42 UTC

Pharmaceuticals sector strength is lifting Viatris Inc during Monday's session, with increased trading volume contributing to the upward movement.

7 ago 2026, 22:01 UTC

Viatris Inc. shares are higher in after-market trading, supported by a broader equity rally following weaker employment data and reduced interest rate hike concerns.

6 ago 2026, 23:01 UTC

Viatris Inc shares are higher in after-market hours, recovering from earlier lows. The stock is trading above Thursday's close despite recent declines.

5 ago 2026, 23:11 UTC

Viatris Inc. shares are trading higher in after-market hours, recovering significantly above the 20-day moving average amid broader market optimism despite no specific news.

4 ago 2026, 23:06 UTC

Viatris Inc shares are higher in after-market trading, reflecting positive momentum and positioning above the 20-day moving average. No specific news was identified.

3 ago 2026, 20:06 UTC

Viatris Inc shares are higher today, reflecting broader market gains led by major stocks. The S&P 500 and Nasdaq 100 have also risen.

31 lug 2026, 21:02 UTC

Viatris Inc shares are lower in after-market hours, continuing a four-session decline amid rising inflation concerns and higher crude oil prices.

Confronto tra pari

Modifica del prezzo

Viatris Inc Previsione

Obiettivo di Prezzo

By TipRanks

18.54% in crescita

Previsioni per 12 mesi

Media 19.571 USD  18.54%

Alto 23 USD

Basso 14 USD

Basato su 7 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Viatris Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

7 ratings

4

Acquista

2

Mantieni

1

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Viatris Inc

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
help-icon Live chat